Works matching AU Shadman, Mazyar

Results: 64
    1

    Perspectives on Current Challenges and Emerging Approaches for Lymphoma Management From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 6, p. e366, doi. 10.1016/j.clml.2025.01.005
    By:
    • Danilov, Alexey V.;
    • Sauter, Craig;
    • Phillips, Tycel;
    • Coombs, Catherine C.;
    • Ip, Andrew;
    • Yucai Wang;
    • Rhodes, Joanna;
    • Leslie, Lori;
    • Barrientos, Jacqueline;
    • Saeed, Hayder;
    • Strati, Paolo;
    • Barta, Stefan K.;
    • Shadman, Mazyar
    Publication type:
    Article
    2
    3
    4

    Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T‐cell therapy: A CIBMTR analysis.

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 3, p. 1202, doi. 10.1111/bjh.19569
    By:
    • Epperla, Narendranath;
    • Hashmi, Hamza;
    • Ahn, Kwang W.;
    • Allbee‐Johnson, Mariam;
    • Chen, Andy I.;
    • Wirk, Baldeep;
    • Kanakry, Jennifer A.;
    • Lekakis, Lazaros;
    • Kharfan‐Dabaja, Mohamed A.;
    • Scordo, Michael;
    • Riedell, Peter A.;
    • Jain, Tania;
    • Shadman, Mazyar;
    • Sauter, Craig;
    • Hamadani, Mehdi;
    • Herrera, Alex F.;
    • Ahmed, Sairah
    Publication type:
    Article
    5

    Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma.

    Published in:
    British Journal of Haematology, 2023, v. 200, n. 1, p. 54, doi. 10.1111/bjh.18467
    By:
    • Furqan, Fateeha;
    • Ahn, Kwang W.;
    • Chen, Yue;
    • Kaur, Manmeet;
    • Abutalib, Syed A.;
    • Ahmed, Nausheen;
    • Ahmed, Sairah;
    • Kharfan‐Dabaja, Mohamed A.;
    • Friedberg, Johnathan;
    • Gregory, Tara;
    • Hill, LaQuisa;
    • Sterling, Cole;
    • Barta, Stephan K.;
    • Shadman, Mazyar;
    • Perales, Miguel‐Angel;
    • Zain, Jasmine;
    • Herrera, Alex F.;
    • Sauter, Craig;
    • Hamadani, Mehdi
    Publication type:
    Article
    6

    The impact of B‐cell‐directed therapy on SARS‐CoV‐2 vaccine efficacy in chronic lymphocytic leukaemia.

    Published in:
    British Journal of Haematology, 2022, v. 197, n. 3, p. 306, doi. 10.1111/bjh.18088
    By:
    • Ujjani, Chaitra;
    • Shadman, Mazyar;
    • Lynch, Ryan C.;
    • Tu, Brian;
    • Stevenson, Philip A.;
    • Grainger, Caitlin;
    • Zhu, Haiying;
    • Hill, Joshua A.;
    • Huang, Meei‐Li;
    • Nielsen, Leslie;
    • Poh, Christina;
    • Sorensen, Tyler;
    • Gopal, Ajay K.;
    • Warren, Edus H.;
    • Till, Brian G.;
    • Lee, Sydney;
    • Gausman, Daria;
    • Smith, Stephen D.;
    • Gooley, Ted;
    • Greninger, Alex
    Publication type:
    Article
    7

    Impact of conditioning regimen intensity on the outcomes of peripheral T‐cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T‐cell lymphoma patients undergoing allogeneic transplant.

    Published in:
    British Journal of Haematology, 2022, v. 197, n. 2, p. 212, doi. 10.1111/bjh.18052
    By:
    • Savani, Malvi;
    • Ahn, Kwang W.;
    • Chen, Yue;
    • Ahmed, Sairah;
    • Cashen, Amanda F.;
    • Shadman, Mazyar;
    • Modi, Dipenkumar;
    • Khimani, Farhad;
    • Cutler, Corey S.;
    • Zain, Jasmine;
    • Brammer, Jonathan E.;
    • Rezvani, Andrew R.;
    • Fenske, Timothy S.;
    • Sauter, Craig S.;
    • Kharfan‐Dabaja, Mohamed A.;
    • Herrera, Alex F.;
    • Hamadani, Mehdi
    Publication type:
    Article
    8

    Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation.

    Published in:
    British Journal of Haematology, 2021, v. 195, n. 5, p. 757, doi. 10.1111/bjh.17865
    By:
    • Riedell, Peter A.;
    • Hamadani, Mehdi;
    • Ahn, Kwang W.;
    • Litovich, Carlos;
    • Brunstein, Claudio G.;
    • Cashen, Amanda F.;
    • Cohen, Jonathon B.;
    • Epperla, Narendranath;
    • Hill, Brian T.;
    • Im, Annie;
    • Inwards, David J.;
    • Lister, John;
    • McCarty, John M.;
    • Ravi Kiran Pingali, Sai;
    • Shadman, Mazyar;
    • Shaughnessy, Paul;
    • Solh, Melhem;
    • Stiff, Patrick J.;
    • Vose, Julie M.;
    • Kharfan-Dabaja, Mohamed A.
    Publication type:
    Article
    9
    10
    11

    Treatment Discontinuation Patterns for Patients With Chronic Lymphocytic Leukemia in Real-World Settings: Results From a Multi-Center International Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 7, p. 515, doi. 10.1016/j.clml.2023.03.010
    By:
    • Shadman, Mazyar;
    • Manzoor, Beenish S.;
    • Sail, Kavita;
    • Tuncer, Hande H.;
    • Allan, John N.;
    • Ujjani, Chaitra;
    • Emechebe, Nnadozie;
    • Kamalakar, Rajesh;
    • Coombs, Catherine C.;
    • Leslie, Lori;
    • Barr, Paul M.;
    • Brown, Jennifer R.;
    • Eyre, Toby A.;
    • Rampotas, Alexandras;
    • Schuh, Anna;
    • Lamanna, Nicole;
    • Skarbnik, Alan;
    • Roeker, Lindsey E.;
    • Bannerji, Rajat;
    • Eichhorst, Barbara
    Publication type:
    Article
    12

    IBCL-373: Updated Experience from Mosunetuzumab in Multiple Relapsed Follicular Lymphoma: Promising Efficacy from a Phase I Trial.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S406, doi. 10.1016/S2152-2650(21)01916-9
    By:
    • Assouline, Sarit;
    • Won Seog Kim;
    • Sehn, Laurie H.;
    • Schuster, Stephen J.;
    • Chan Yoon Cheah;
    • Nastoupil, Loretta J.;
    • Shadman, Mazyar;
    • Sung-Soo Yoon;
    • Matasar, Matthew J.;
    • Diefenbach, Catherine;
    • Gregory, Gareth P.;
    • Bartlett, Nancy L.;
    • Wei, Michael C.;
    • Doral, Michelle Y.;
    • Shen Yin;
    • Negricea, Raluca;
    • Chi-Chung Li;
    • Penuel, Elicia;
    • Huang Huang;
    • Budde, L. Elizabeth
    Publication type:
    Article
    13

    Poster: IBCL-373: Updated Experience from Mosunetuzumab in Multiple Relapsed Follicular Lymphoma: Promising Efficacy from a Phase I Trial.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S245, doi. 10.1016/S2152-2650(21)01540-8
    By:
    • Assouline, Sarit;
    • Kim, Won Seog;
    • Sehn, Laurie H.;
    • Schuster, Stephen J.;
    • Cheah, Chan Yoon;
    • Nastoupil, Loretta J.;
    • Shadman, Mazyar;
    • Yoon, Sung-Soo;
    • Matasar, Matthew J.;
    • Diefenbach, Catherine;
    • Gregory, Gareth P.;
    • Bartlett, Nancy L.;
    • Wei, Michael C.;
    • Doral, Michelle Y.;
    • Yin, Shen;
    • Negricea, Raluca;
    • Li, Chi-Chung;
    • Penuel, Elicia;
    • Huang, Huang;
    • Budde, L. Elizabeth
    Publication type:
    Article
    14
    15

    Managing Cytokine Release Syndrome and Neurotoxicity with Step-Up Dosing of Mosunetuzumab in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S247, doi. 10.1016/j.clml.2019.07.151
    By:
    • Bartlett, Nancy L.;
    • Sehn, Laurie H.;
    • Assouline, Sarit;
    • Bosch, Francesc;
    • Diefenbach, Catherine M.;
    • Flinn, Ian;
    • Hong, Jung Yong;
    • Kim, Wonseog S.;
    • Matasar, Matthew;
    • Nastoupil, Loretta;
    • Schuster, Stephen J.;
    • Shadman, Mazyar;
    • Yoon, Sung-Soo;
    • Bender, Brendan;
    • Chu, Wayne;
    • Hernandez, Genevive;
    • Kwan, Antonia;
    • McCall, Bruce;
    • Sison, Iris;
    • Wang, Cunlin
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real‐world setting. A GIMEMA‐ERIC and US study.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 22, p. 8468, doi. 10.1002/cam4.3470
    By:
    • Cuneo, Antonio;
    • Mato, Anthony R.;
    • Rigolin, Gian Matteo;
    • Piciocchi, Alfonso;
    • Gentile, Massimo;
    • Laurenti, Luca;
    • Allan, John N.;
    • Pagel, John M.;
    • Brander, Danielle M.;
    • Hill, Brian T.;
    • Winter, Allison;
    • Lamanna, Nicole;
    • Tam, Constantine S.;
    • Jacobs, Ryan;
    • Lansigan, Frederick;
    • Barr, Paul M.;
    • Shadman, Mazyar;
    • Skarbnik, Alan P.;
    • Pu, Jeffrey J.;
    • Sehgal, Alison R.
    Publication type:
    Article
    28
    29
    30
    31

    The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia.

    Published in:
    British Journal of Haematology, 2020, v. 188, n. 6, p. 918, doi. 10.1111/bjh.16271
    By:
    • Eyre, Toby A.;
    • Roeker, Lindsey E.;
    • Fox, Christopher P.;
    • Gohill, Satyen H.;
    • Walewska, Renata;
    • Walter, Harriet S.;
    • Forconi, Francesco;
    • Broom, Angus;
    • Arumainathan, Arvind;
    • Brander, Danielle M.;
    • Allan, John N.;
    • Schuster, Stephen J.;
    • Hill, Brian T.;
    • Lansigan, Frederick;
    • Cheson, Bruce D.;
    • Lamanna, Nicole;
    • Coombs, Catherine C.;
    • Barr, Paul M.;
    • Skarbnik, Alan P.;
    • Shadman, Mazyar
    Publication type:
    Article
    32

    Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design.

    Published in:
    British Journal of Haematology, 2014, v. 166, n. 3, p. 375, doi. 10.1111/bjh.12905
    By:
    • Lionberger, Jack M.;
    • Pagel, John M.;
    • Sandhu, Vicky K.;
    • Xie, Hu;
    • Shadman, Mazyar;
    • Mawad, Raya;
    • Boehm, Alexandra;
    • Dean, Carol;
    • Shannon‐Dorcy, Kathleen;
    • Scott, Bart L.;
    • Deeg, Hans Joachim;
    • Becker, Pamela S.;
    • Hendrie, Paul C.;
    • Walter, Roland B.;
    • Ostronoff, Fabiana;
    • Appelbaum, Frederick R.;
    • Estey, Elihu H.
    Publication type:
    Article
    33

    Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia.

    Published in:
    British Journal of Haematology, 2010, v. 148, n. 1, p. 48, doi. 10.1111/j.1365-2141.2009.07919.x
    By:
    • Chauncey, Thomas R.;
    • Gundacker, Holly;
    • Shadman, Mazyar;
    • List, Alan F.;
    • Dakhil, Shaker R.;
    • Erba, Harry P.;
    • Slovak, Marilyn L.;
    • I-Ming Chen;
    • Willman, Cheryl L.;
    • Kopecky, Kenneth J.;
    • Appelbaum, Frederick R.
    Publication type:
    Article
    34
    35
    36

    Predictors of response to axicabtagene‐ciloleucel CAR T cells in aggressive B cell lymphomas: A real‐world study.

    Published in:
    Journal of Cellular & Molecular Medicine, 2022, v. 26, n. 24, p. 5976, doi. 10.1111/jcmm.17550
    By:
    • Iovino, Lorenzo;
    • Wu, Qian Vicky;
    • Voutsinas, Jenna;
    • Panaite, Lorena;
    • Mullane, Erin;
    • Lynch, Ryan C.;
    • Ujjani, Chaitra;
    • Smith, Stephen D.;
    • Gopal, Ajay K.;
    • Till, Brian G.;
    • Milano, Filippo;
    • Chow, Victor;
    • Gauthier, Jordan;
    • Turtle, Cameron J.;
    • Maloney, David G.;
    • Shadman, Mazyar
    Publication type:
    Article
    37
    38
    39

    First interim analysis of alpine study: results of a phase 3 randomized study of zanubrutinib vs. ibrutinib in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

    Published in:
    Acta Haematologica Polonica, 2022, v. 53, n. A, p. 32
    By:
    • Jurczak, Wojciech;
    • Eichhorst, Barbara;
    • Brown, Jennifer J.;
    • Lamanna, Nicole;
    • O'Brien, Susan;
    • Tam, Constantine S.;
    • Lugui Qiu;
    • Kazmierczak, Maciej;
    • Zhou, Keshu;
    • Šimkovič, Martin;
    • Mayer, Jiri;
    • Gillespie-Twardy, Amanda;
    • Shadman, Mazyar;
    • Ferrajoli, Alessandra;
    • Ganly, Peter S.;
    • Weinkove, Robert;
    • Salmi, Tommi;
    • Wu, Kenneth;
    • Novotny, William;
    • Hillmen, Peter
    Publication type:
    Article
    40

    SEQUOIA: results of a phase 3 randomized study of Zanubrutinib versus Bendamustine + Rituximab (BR) in patients with treatment-naive chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

    Published in:
    Acta Haematologica Polonica, 2022, v. 53, n. A, p. 32
    By:
    • Robak, Tadeusz;
    • Giannopoulos, Krzysztof;
    • Jurczak, Wojciech;
    • Šimkovič, Martin;
    • Shadman, Mazyar;
    • Österborg, Anders;
    • Laurenti, Luca;
    • Walker, Patricia;
    • Opat, Stephen;
    • Chan, Henry;
    • Ciepluch, Hanna;
    • Greil, Richard;
    • Tani, Monica;
    • Trněný, Marek;
    • Brander, Danielle M.;
    • Flinn, Ian W.;
    • Grosicki, Sebastian;
    • Verner, Emma;
    • Kahl, Brad S.;
    • Ghia, Paolo
    Publication type:
    Article
    41

    Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01084-w
    By:
    • Shadman, Mazyar;
    • Ahn, Kwang W.;
    • Kaur, Manmeet;
    • Lekakis, Lazaros;
    • Beitinjaneh, Amer;
    • Iqbal, Madiha;
    • Ahmed, Nausheen;
    • Hill, Brian;
    • Hossain, Nasheed M.;
    • Riedell, Peter;
    • Gopal, Ajay K.;
    • Grover, Natalie;
    • Frigault, Matthew;
    • Brammer, Jonathan;
    • Ghosh, Nilanjan;
    • Merryman, Reid;
    • Lazaryan, Aleksandr;
    • Ram, Ron;
    • Hertzberg, Mark;
    • Savani, Bipin
    Publication type:
    Article
    42
    43
    44
    45
    46

    Chimeric antigen receptor T‐cell therapy in secondary central nervous system lymphoma: A multicenter analysis.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 8, p. 1624, doi. 10.1002/ajh.27354
    By:
    • Alsouqi, Aseel;
    • Ahmed, Gulrayz;
    • Wang, Juntian;
    • Cassanello, Giulio;
    • Szabo, Aniko;
    • Rojek, Alexandra E.;
    • Riedell, Peter A.;
    • Awan, Farrukh;
    • Samples, Laura;
    • Shadman, Mazyar;
    • Hu, Marie;
    • Bachanova, Veronika;
    • Wesson, William;
    • Ahmed, Nausheen;
    • Iqbal, Madiha;
    • Kharfan‐Dabaja, Mohamed A.;
    • Scordo, Michael;
    • Johnson, P. Connor;
    • Chen, Yi‐Bin;
    • Ito, Sawa
    Publication type:
    Article
    47
    48
    49
    50

    Outcomes of patients with large B‐cell lymphomas and progressive disease following CD19‐specific CAR T‐cell therapy.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 8, p. E209, doi. 10.1002/ajh.25505
    By:
    • Chow, Victor A.;
    • Gopal, Ajay K.;
    • Maloney, David G.;
    • Turtle, Cameron J.;
    • Smith, Stephen D.;
    • Ujjani, Chaitra S.;
    • Shadman, Mazyar;
    • Cassaday, Ryan D.;
    • Till, Brian G.;
    • Tseng, Yolanda D.;
    • Warren, Edus H.;
    • Shustov, Andrei R.;
    • Menon, Manoj P.;
    • Bhark, Sandra;
    • Acharya, Utkarsh H.;
    • Mullane, Erin;
    • Hannan, Lindsay M.;
    • Voutsinas, Jenna M.;
    • Gooley, Ted A.;
    • Lynch, Ryan C.
    Publication type:
    Article